Pharmabiz

Scienture and BlinkRx collaborate to expand patient access to Arbli, an oral suspension formulation of losartan potassium

Scienture and BlinkRx collaborate to expand patient access to Arbli, an oral suspension formulation of losartan potassium: Commack, New York Friday, December 12, 2025, 14:00 Hrs [ ...
Pharmabiz

Diakonos Oncology gets grant from Cancer Prevention and Research Institute of Texas to advance DOC1021 in refractory melanoma

Diakonos Oncology gets grant from Cancer Prevention and Research Institute of Texas to advance DOC1021 in refractory melanoma: Houston Friday, December 12, 2025, 13:00 Hrs [IST] D ...
Pharmabiz

Ajax Therapeutics receives US FDA’s Orphan Drug Designation for AJ1-11095 to treat patients with myelofibrosis

Ajax Therapeutics receives US FDA’s Orphan Drug Designation for AJ1-11095 to treat patients with myelofibrosis: New York Friday, December 12, 2025, 12:00 Hrs [IST] Ajax Therapeu ...
Pharmabiz

Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu

Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu: Basel Friday, December 12 ...
Pharmabiz

Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer

Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer: New York Friday, December 12, ...
Pharmabiz

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
Pharmabiz

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220: Peethaambaran ...
Pharmabiz

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [I ...
Pharmabiz

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [IST] T ...
Pharmabiz

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance: Shardul Nautiyal, Mumbai Friday, December 12, 2025, 08:00 Hrs [IST] The Directorate Gen ...
Pharmabiz

Marchesini Group and AST ink partnership to strengthen aseptic production capacity and expand global market presence

Marchesini Group and AST ink partnership to strengthen aseptic production capacity and expand global market presence: Bologna, Italy Thursday, December 11, 2025, 18:00 Hrs [IST] M ...
Pharmabiz

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025: Our Bureau, Bengaluru Thursday, December 11, 2025, 17:30 Hrs [IST] Senores Pharmaceuticals is i ...